Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
- 1 December 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 63 (6) , 1070-1079
- https://doi.org/10.1161/01.res.63.6.1070
Abstract
The cardio-protective effects of neutrophil depletion or inhibition of neutrophil activation early in the course of myocardial reperfusion has been established. Whether these treatments would be effective during extended periods of reperfusion has not been ascertained. Open-chest anesthetized dogs were subjected to left circumflex artery (LCX) occlusion for 90 minutes followed by 72 hours of reperfusion. Dogs were randomized into one of four groups: 1) control; 2) Ilo-2 (iloprost 100 ng/kg/min administered via the left atrium beginning 10 minutes after LCX occlusion and continuing 2 hours into reperfusion); 3) Ilo-48 (iloprost 100 ng/kg/min administered as above until 1 hour after reperfusion then 25 ng/kg/min for 48 hours of reperfusion; or 4) antibody (neutrophil antibody administered before occlusion and 1/2 hourly for 2 hours of reperfusion and then every 24 hours). Myocardial infarct size, as a percentage of the area at risk assessed after 72 hours of reperfusion, was significantly smaller in the antibody-treated group (32.1 +/- 5.0% mean +/- SEM) or Ilo-48 (22.6 +/- 4.0%) treatment group compared with control (48.7 +/- 5.6%) or Ilo-2 (57.6 +/- 5.2%) groups. Regional myocardial blood flow studies demonstrated that all groups developed similar degrees of ischemia. The iloprost-treated groups had lower mean arterial blood pressures during occlusion and reperfusion than groups 1 and 4 (p less than 0.05). Circulating neutrophil counts were increased in groups 1 and 2 at 24 and 48 hours after reperfusion compared to groups 3 and 4 (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 29 references indexed in Scilit:
- Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardiumJournal of Molecular and Cellular Cardiology, 1987
- Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activationAmerican Heart Journal, 1987
- Does infarct size influence loss of embolised 15-μm microspheres from ischaemic myocardium?Scandinavian Journal of Clinical and Laboratory Investigation, 1986
- Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophilsBiochemical and Biophysical Research Communications, 1983
- Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay?The American Journal of Cardiology, 1983
- Determinants of arrhythmic death due to coronary spasm: effect of preexisting coronary artery stenosis on the incidence of reperfusion arrhythmia.Circulation, 1982
- Prostacyclin in experimental myocardial ischemia: Effects on hemodynamics, regional myocardial blood flow, infarct size and mortalityThe American Journal of Cardiology, 1981
- Changes in myocardial oxygen consumption 45 minutes after experimental coronary occlusion do not alter infarct sizeCardiovascular Research, 1980
- The relationship between coronary artery lesions and myocardial infarcts: Ulceration of atherosclerotic plaques precipitating coronary thrombosisAmerican Heart Journal, 1977
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964